These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24631395)

  • 1. Peripheral administration of poly I:C leads to increased hippocampal amyloid-beta and cognitive deficits in a non-transgenic mouse.
    Weintraub MK; Kranjac D; Eimerbrink MJ; Pearson SJ; Vinson BT; Patel J; Summers WM; Parnell TB; Boehm GW; Chumley MJ
    Behav Brain Res; 2014 Jun; 266():183-7. PubMed ID: 24631395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse.
    Kahn MS; Kranjac D; Alonzo CA; Haase JH; Cedillos RO; McLinden KA; Boehm GW; Chumley MJ
    Behav Brain Res; 2012 Apr; 229(1):176-84. PubMed ID: 22249135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
    Weintraub MK; Bisson CM; Nouri JN; Vinson BT; Eimerbrink MJ; Kranjac D; Boehm GW; Chumley MJ
    Brain Behav Immun; 2013 Oct; 33():24-8. PubMed ID: 23665252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration.
    White JD; Eimerbrink MJ; Hayes HB; Hardy A; Van Enkevort EA; Peterman JL; Chumley MJ; Boehm GW
    Behav Brain Res; 2016 Oct; 313():219-225. PubMed ID: 27449203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The α5-GABA
    Eimerbrink MJ; Pendry RJ; Hodges SL; Wiles JD; Peterman JL; White JD; Hayes HB; Chumley MJ; Boehm GW
    Behav Brain Res; 2019 Feb; 359():871-877. PubMed ID: 30031883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
    Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
    Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
    Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
    J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
    Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
    Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
    Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
    Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.